Co-op: R&D Learning
Posted on: 30 Jan 2021
Cambridge, MA
Job Description
Job Description
This is for a 6-month full-time co-op from July to December 2021
The Co-op employee in R&D Learning and Development is working within a small team of training specialists and is part of Global Enterprise Learning. Learning Partners within R&D Learning with cost centers within R&D functional units. We:
* Consult on learning needs,
* Design and develop learning solutions,
* Align learning solutions with business initiatives
Position Description
The R&D Learning Co-op in R&D Learning will:
* Support the Learning Partner to develop, plan, and organize learning needs, projects and initiatives within GSRS functional area
* Support development, deployment, and aggregation of Level 1 Assessments
* Develop, maintain, and update project plans for learning solutions
Day-to-day Responsibilities:
* Review and update project plans for current learning solutions
* Schedule meetings, workshops, conferences as needed
* Maintain 95% training completion
* Work within R&D Learning systems effectively and efficiently
* Attendance and participation at team and manager meetings
Overview of Projects:
* Stage 2 QMS Integration Training Analysis for Biogen Affiliates
* Business Process Overviews of GSRS functional areas
Brief Project Outline:
The key learning objectives are:
* Ability to clearly define milestones in a project
* Success at meeting milestones
* Ability to assess business content to make it consumable for the learner
Outcomes expected:
Successfully:
* Assess learning strategies and applications
* Manage multiple demands on time and attention
* Collaborate with team members, managers, and business stakeholders
Skills and attributes needed:
* Flexibility in approach to projects and differing learning styles
* Desire to learn, develop and test new capabilities in learning at Biogen
* Interest in, or, familiarity with biopharmaceutical industry
* Presentation skills
* Familiarity with Microsoft Office products and training applications, e.g., Zoom, MS Teams, MS Forms
Qualifications
To participate in the Biogen Internship Program, students must meet the following eligibility criteria:
Legal authorization to work in the U.S.
Grade point average of 3.2 or higher preferred
At least 18 years of age prior to the scheduled start date
Be currently enrolled in an accredited college or university
Education
Current Bachelors Degree Candidate
Location
Cambridge, MA (Can be performed 100% remote)
Additional Information
All your information will be kept confidential according to EEO guidelines.
Biogen
Cambridge, MA
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.
Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.
The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
IndustryBiotechnology
-
No. of Employees7,800
-
Website
-
Jobs Posted445
